与LMNA相关的扩张性心肌病的多层次转录基因分析确定了疾病驱动过程
bioRxiv : the preprint server for biology
|June 25, 2024
概括
与LMNA相关的扩张性心肌病 (LMNA-DCM) 涉及DNA损伤和心脏细胞中的免疫激活. 心肌细胞和其他细胞的早期基因变化驱动了这种严重的心脏病,突出了新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子遗传学 分子遗传学
- 免疫学 免疫学 免疫学
背景情况:
- 与LMNA相关的扩张性心肌病 (LMNA-DCM) 是一种严重的心脏病,由于对分子机制的了解不足,死亡率高.
- 目前LMNA-DCM的治疗选择有限,需要对疾病驱动因素进行研究.
研究的目的:
- 综合调查分子机制,并确定LMNA-DCM进展的关键驱动因素.
- 阐明DNA损伤,先天性免疫和细胞间通信在LMNA-DCM病变发生过程中的作用.
主要方法:
- 使用一种可诱导的,心肌细胞特异的层状空气消耗小鼠模型.
- 在疾病进展过程中进行了集成批量和单核RNA测序.
- 开发了一种精细的分析管道,以识别早期错误调节的基因.
主要成果:
- 鉴定了LMNA-DCM早期错误调节的496个基因,由心肌细胞亚群驱动.
- 观察到心肌细胞中DNA损伤增加,与降低的层层A水平相关.
- 发现了细胞质模式识别途径激活和免疫细胞透的证据,以及心脏纤维细胞基因表达的改变.
结论:
- 心肌细胞中的核损伤启动了DNA损伤反应和先天性免疫激活,有助于LMNA-DCM.
- 心肌细胞,纤维细胞和免疫细胞之间的细胞间通信发生变化,由细胞外基质变化介导,起着至关重要的作用.
- 研究结果表明,多面性病原发生涉及炎症和转录重塑,提供潜在的治疗点.
更多相关视频
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.0K
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.1K
相关概念视频
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
